Literature DB >> 6730426

Inhibition of serological reactions with enzyme-treated red cells by complement binding alloantibodies.

J A Lown, P A Holland, A L Barr.   

Abstract

Complement-binding antibodies (2 examples of anti-Jka and 2 anti-kell) which inhibit agglutination of enzyme-treated cells have been investigated in the sera of 4 patients. The sera containing anti-Jka also contained rhesus antibodies (c + E and D + C) which could not be readily identified by an enzyme technique due to failure of the Jka+ cells of the corresponding Rh phenotype to react. The inhibition of the enzyme test reactivity was revealed using a control reagent added to each test after the initial examination for agglutination. Addition of ethylenediaminetetraacetic acid to the sera prior to testing resulted in identifiable reactivity with panel red cells. Failure to recognise this phenomenon in sera containing antibodies reacting only by an enzyme technique could result in misidentification, delay in providing compatible blood and transfusion of incompatible blood. Routine control of enzyme tests to detect false-negative results is recommended.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6730426     DOI: 10.1111/j.1423-0410.1984.tb00090.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  2 in total

1.  A novel observation on grouping anomaly: The phenomena mimicking the Bel genetic variant of the ABO blood groups.

Authors:  Sanmukh R Joshi; Ashish N Kanani; Snehal B Senjaliya; Manisha M Rajapara
Journal:  Asian J Transfus Sci       Date:  2021-06-12

2.  The prozone effect exerted by the complement-binding anti-Lea on anti-D.

Authors:  Sanmukh R Joshi; Kamlesh H Parekh
Journal:  Asian J Transfus Sci       Date:  2017 Jul-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.